Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy

ClinicalTrials.gov ID: NCT00004985

Public ClinicalTrials.gov record NCT00004985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Single-Blind, Randomized, Placebo-Controlled Study of Capravirine (AG1549) in Combination With Viracept and Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Subjects Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to look at the effectiveness of an anti-HIV drug combination that adds capravirine in patients who have failed their first drug combination treatment.

Study identification

NCT ID
NCT00004985
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Agouron Pharmaceuticals
Industry
Enrollment
75 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1999
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

Started 2000

United States locations

U.S. sites
33
U.S. states
10
U.S. cities
28
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85016
Pacific Oaks Med Group Beverly Hills California 90211
First Choice Medical Palm Springs California 92262
Apogee Med Group San Diego California 92101
Saint Francis Mem Hosp / HIV Care Unit San Francisco California 94109
Kaiser Foundation Hospital San Francisco California 94118
Harbor - UCLA Med Ctr Torrance California 90502
Univ of Colorado Health Sciences Ctr Denver Colorado 80262
Bach and Godofsky Bradenton Florida 34205
Clin Research of West Florida Clearwater Florida 33765
Community Health Care Fort Lauderdale Florida 33306
Therafirst Med Ctr Fort Lauderdale Florida 33308
South Shore Hosp Miami Florida 33139
Immunity Care and Research Inc Miami Beach Florida 33139
Orange County Health Dept Orlando Florida 32805
Infectious Diseases Associates Sarasota Florida 34239
Hillsborough County Health Dept Tampa Florida 33602
Treasure Coast Infectious Disease Consultants Vero Beach Florida 32960
Polk County Health Dept Winter Haven Florida 33881
AIDS Research Consortium of Atlanta Atlanta Georgia 30308
Braude Mermin Spivey MD PC Atlanta Georgia 30309
Massachusetts Gen Hosp Boston Massachusetts 02114
Fenway Community Health Ctr Boston Massachusetts 02115
VAMC New Jersey Healthcare System East Orange New Jersey 07018
Jersey Shore Med Ctr Neptune City New Jersey 07753
Infectious Disease Assoc of Central Jersey Somerville New Jersey 08876
Biomedical Research Alliance of New York Jamaica New York 11432
North Shore Univ Hosp Manhasset New York 11030
Liberty Medical New York New York 10014
Mount Sinai Med Ctr New York New York 10029
Central Texas Clinical Research Austin Texas 78705
Univ TX Galveston Med Branch Galveston Texas 77555
Infectious Disease Physicians Inc Annandale Virginia 22203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004985 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →